Renal Insufficiency, Chronic
"Renal Insufficiency, Chronic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Conditions in which the KIDNEYS perform below the normal level for more than three months. Chronic kidney insufficiency is classified by five stages according to the decline in GLOMERULAR FILTRATION RATE and the degree of kidney damage (as measured by the level of PROTEINURIA). The most severe form is the end-stage renal disease (CHRONIC KIDNEY FAILURE). (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002)
| Descriptor ID |
D051436
|
| MeSH Number(s) |
C12.777.419.780.750 C13.351.968.419.780.750
|
| Concept/Terms |
Renal Insufficiency, Chronic- Renal Insufficiency, Chronic
- Chronic Renal Insufficiencies
- Renal Insufficiencies, Chronic
- Chronic Renal Insufficiency
- Kidney Insufficiency, Chronic
- Chronic Kidney Insufficiency
- Chronic Kidney Insufficiencies
- Kidney Insufficiencies, Chronic
Chronic Kidney Diseases- Chronic Kidney Diseases
- Chronic Kidney Disease
- Disease, Chronic Kidney
- Diseases, Chronic Kidney
- Kidney Disease, Chronic
- Kidney Diseases, Chronic
- Chronic Renal Diseases
- Chronic Renal Disease
- Disease, Chronic Renal
- Diseases, Chronic Renal
- Renal Disease, Chronic
- Renal Diseases, Chronic
|
Below are MeSH descriptors whose meaning is more general than "Renal Insufficiency, Chronic".
Below are MeSH descriptors whose meaning is more specific than "Renal Insufficiency, Chronic".
This graph shows the total number of publications written about "Renal Insufficiency, Chronic" by people in this website by year, and whether "Renal Insufficiency, Chronic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 2 | 0 | 2 |
| 2008 | 3 | 0 | 3 |
| 2009 | 3 | 1 | 4 |
| 2010 | 7 | 2 | 9 |
| 2011 | 6 | 0 | 6 |
| 2012 | 7 | 4 | 11 |
| 2013 | 21 | 3 | 24 |
| 2014 | 18 | 4 | 22 |
| 2015 | 20 | 3 | 23 |
| 2016 | 11 | 1 | 12 |
| 2017 | 17 | 6 | 23 |
| 2018 | 15 | 3 | 18 |
| 2019 | 20 | 1 | 21 |
| 2020 | 22 | 4 | 26 |
| 2021 | 24 | 3 | 27 |
| 2022 | 38 | 1 | 39 |
| 2023 | 20 | 0 | 20 |
To return to the timeline,
click here.
Below are the most recent publications written about "Renal Insufficiency, Chronic" by people in Profiles.
-
The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease. Nephrol Dial Transplant. 2023 Aug 31; 38(9):2041-2051.
-
Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone. JAMA Cardiol. 2023 08 01; 8(8):732-741.
-
The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the FIDELITY study. Diabetes Obes Metab. 2023 10; 25(10):2989-2998.
-
Chronic Kidney Disease After Liver Transplantation. Adv Kidney Dis Health. 2023 Jul; 30(4):368-377.
-
Effect of SGLT2 Inhibitors on Cardiovascular Outcomes Across Various Patient Populations. J Am Coll Cardiol. 2023 06 27; 81(25):2377-2387.
-
Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE Trials. J Am Heart Assoc. 2023 07 04; 12(13):e028516.
-
Comparison of the effectiveness and safety of 2 aspirin doses in secondary prevention of cardiovascular outcomes in patients with chronic kidney disease: A subgroup analysis of ADAPTABLE. Am Heart J. 2023 Oct; 264:31-39.
-
Sel1-like proteins and peptides are the major Oxalobacter formigenes-derived factors stimulating oxalate transport by human intestinal epithelial cells. Am J Physiol Cell Physiol. 2023 Jul 01; 325(1):C344-C361.
-
Assessing the Risk of Postoperative Complications for Proximal Humeral Fractures Treated by Open Reduction and Internal Fixation in Patients With Diabetes and Chronic Kidney Disease. J Am Acad Orthop Surg Glob Res Rev. 2023 05 01; 7(5).
-
Effects of newer kidney protective agents on kidney endpoints provide implications for future clinical trials. Kidney Int. 2023 Jul; 104(1):181-188.